Rapid viral escape at an immunodominant simian-human immunodeficiency virus cytotoxic T-lymphocyte epitope exacts a dramatic fitness cost

被引:148
作者
Fernandez, CS
Stratov, I
De Rose, R
Walsh, K
Dale, CJ
Smith, MZ
Agy, MB
Hu, SL
Krebs, K
Watkins, DI
O'Connor, DH
Davenport, MP
Kent, SJ [1 ]
机构
[1] Univ Melbourne, Dept Microbiol & Immunol, Melbourne, Vic 3010, Australia
[2] Univ Washington, Natl Primate Res Ctr, Seattle, WA 98105 USA
[3] Natl Primate Res Ctr, Madison, WI 53715 USA
[4] Univ New S Wales, Ctr Vasc Res, Kensington, NSW 2052, Australia
[5] Prince Wales Hosp, Dept Haematol, Kensington, NSW 2052, Australia
关键词
D O I
10.1128/JVI.79.9.5721-5731.2005
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Escape from specific T-cell responses contributes to the progression of human immunodeficiency virus type 1 (HIV-1) infection. T-cell escape viral variants are retained following HIV-1 transmission between major histocompatibility complex (MHC)-matched individuals. However, reversion to wild type can occur following transmission to MHC-mismatched hosts in the absence of cytotoxic T-lymphocyte (CTL) pressure, due to the reduced fitness of the escape mutant virus. We estimated both the strength of immune selection and the fitness cost of escape variants by studying the rates of T-cell escape and reversion in pigtail macaques. Near-complete replacement of wild-type with T-cell escape viral variants at an immunodominant simian immunodeficiency virus Gag epitope KP9 occurred rapidly (over 7 days) following infection of pigtail macaques with SHIVSF162P3* Another challenge virus, SHIVmn229, previously serially passaged through pigtail macaques, contained a KP9 escape mutation in 40/44 clones sequenced from the challenge stock. When six KP9-responding animals were infected with this virus, the escape mutation was maintained. By contrast, in animals not responding to KP9, rapid reversion of the K165R mutation occurred over 2 weeks after infection. The rapidity of reversion to the wild-type sequence suggests a significant fitness cost of the T-cell escape mutant. Quantifying both the selection pressure exerted by CTL and the fitness costs of escape mutation has important implications for the development of CTL-based vaccine strategies.
引用
收藏
页码:5721 / 5731
页数:11
相关论文
共 32 条
  • [1] Tat-specific cytotoxic T lymphocytes select for SIV escape variants during resolution of primary viraemia
    Allen, TM
    O'Connor, DH
    Jing, PC
    Dzuris, JL
    Mothé, BR
    Vogel, TU
    Dunphy, E
    Liebl, ME
    Emerson, C
    Wilson, N
    Kunstman, KJ
    Wang, XC
    Allison, DB
    Hughes, AL
    Desrosiers, RC
    Altman, JD
    Wolinsky, SM
    Sette, A
    Watkins, DI
    [J]. NATURE, 2000, 407 (6802) : 386 - 390
  • [2] High resolution HLA class I typing by reference strand mediated conformation analysis (RSCA)
    Argüello, JR
    Little, AM
    Bohan, E
    Goldman, JM
    Marsh, SGE
    Madrigal, JA
    [J]. TISSUE ANTIGENS, 1998, 52 (01): : 57 - 66
  • [3] Control of viremia and prevention of clinical AIDS in rhesus monkeys by cytokine-augmented DNA vaccination
    Barouch, DH
    Santra, S
    Schmitz, JE
    Kuroda, MJ
    Fu, TM
    Wagner, W
    Bilska, M
    Craiu, A
    Zheng, XX
    Krivulka, GR
    Beaudry, K
    Lifton, MA
    Nickerson, CE
    Trigona, WL
    Punt, K
    Freed, DC
    Guan, LM
    Dubey, S
    Casimiro, D
    Simon, A
    Davies, ME
    Chastain, M
    Strom, TB
    Gelman, RS
    Montefiori, DC
    Lewis, MG
    Emini, EA
    Shiver, JW
    Letvin, NL
    [J]. SCIENCE, 2000, 290 (5491) : 486 - 492
  • [4] Procedures for reliable estimation of viral fitness from time-series data
    Bonhoeffer, S
    Barbour, AD
    De Boer, RJ
    [J]. PROCEEDINGS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES, 2002, 269 (1503) : 1887 - 1893
  • [5] Borroto R J, 1997, Rev Panam Salud Publica, V1, P3
  • [6] Evolution of CD8+ T cell immunity and viral escape following acute HIV-1 infection
    Cao, JH
    McNevin, J
    Malhotra, U
    McElrath, MJ
    [J]. JOURNAL OF IMMUNOLOGY, 2003, 171 (07) : 3837 - 3846
  • [7] Efficacy of DNA and fowlpox virus priming/boosting vaccines for simian/human immunodeficiency virus
    Dale, CJ
    De Rose, R
    Stratov, I
    Chea, S
    Montefiori, DC
    Thomson, S
    Ramshaw, IA
    Coupar, BEH
    Boyle, DB
    Law, M
    Kent, SJ
    [J]. JOURNAL OF VIROLOGY, 2004, 78 (24) : 13819 - 13828
  • [8] Chimeric human papilloma virus-simian/human immunodeficiency virus virus-like-particle vaccines: Immunogenicity and protective efficacy in macaques
    Dale, CJ
    Liu, XSS
    De Rose, R
    Purcell, DFJ
    Anderson, J
    Xu, Y
    Leggatt, GR
    Frazer, IH
    Kent, SJ
    [J]. VIROLOGY, 2002, 301 (01) : 176 - 187
  • [9] Reversion of CTL escape-variant immunodeficiency viruses in vivo
    Friedrich, TC
    Dodds, EJ
    Yant, LJ
    Vojnov, L
    Rudersdorf, R
    Cullen, C
    Evans, DT
    Desrosiers, RC
    Mothé, BR
    Sidney, J
    Sette, A
    Kunstman, K
    Wolinsky, S
    Piatak, M
    Lifson, J
    Hughes, AL
    Wilson, N
    O'Connor, DH
    Watkins, DI
    [J]. NATURE MEDICINE, 2004, 10 (03) : 275 - 281
  • [10] Extraepitopic compensatory substitutions partially restore fitness to simian immunodeficiency virus variants that escape from an immunodominant cytotoxic-T-lymphocyte response
    Friedrich, TC
    Frye, CA
    Yant, LJ
    O'Connor, DH
    Kriewaldt, NA
    Benson, M
    Vojnov, L
    Dodds, EJ
    Cullen, C
    Rudersdorf, R
    Hughes, AL
    Wilson, N
    Watkins, DI
    [J]. JOURNAL OF VIROLOGY, 2004, 78 (05) : 2581 - 2585